Skip to main content
padlock icon - secure page this page is secure

18F-FDG PET/CT Demonstrates Efficacy and Limitations of Hepatic Arterial Infusion Chemotherapy for Treating Colorectal Liver Metastases

Buy Article:

$68.00 + tax (Refund Policy)

Hepatic arterial infusion chemotherapy (HAIC) is a palliative therapy option for advanced, unresectable liver metastases from colorectal carcinoma. A woman with multiple colorectal liver metastases was treated with HAIC and systemic chemotherapy. Serial 18F-FDG PET/CT imaging showed local therapeutic response of liver metastases to regional delivery of chemotherapy, but concurrent disease progression at extra-hepatic sites suggesting ineffective systemic chemotherapy. Hepatic disease also progressed in the caudate lobe, likely due to variable regional arterial supply. This case is illustrative of the rationale for HAIC in the management of inoperable hepatic metastases and also demonstrates limitations of this approach.





No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: 18F-FDG PET/CT; 5-fluorouracil; 9m Tc-macroaggregated albumin; CT angiogram; Colorectal Liver Metastases; FDG-PET/CT; Hartmann's; celiac axis; colorectal; colorectal carcinoma; colorectal carcinoma HAIC; colostomy; common hepatic artery; floxuridine; gastroduodenal artery; hepatic arterial infusion chemotherapy; hepatic metastases; hepatic metastatic lesions; hepatic neoplasm; hepatic tissue; left hepatic artery; leucovorin; liver disease; liver metastases; macroaggregated albumin; metastatic liver disease; neuroendocrine; oligometastases; oxaliplatin; post-radiation fibrosis; proper hepatic artery; radionuclide chemo-embolization therapy; rectum; right hepatic artery; sigmoidectomy; solitary metastasis; superior mesenteric artery; systemic chemotherapy

Document Type: Research Article

Publication date: October 1, 2010

More about this publication?
  • Current Radiopharmaceuticals publishes original research articles, letters, reviews, drug clinical trial studies and guest edited issues on all aspects of research and development of radiolabelled compound preparations. The scope of the journal covers the following areas: radio imaging techniques, therapies; preparation and application of radionuclide compounds including the incorporation of tracer methods used in scientific research and applications.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more